In college, Tim Urban’s procrastination problem got so bad that he found himself writing the first word of his 90-page senior thesis only 72 hours before it was due. After spending years trying to understand how his own mind worked, he finally put his thoughts down on paper, creating three cartoon stick drawings — the Rational Decision-Maker, the Instant Gratification Monkey and the Panic Monster — to represent the major “players” in his head that battled over the steering wheel. In a hilarious presentation, Urban takes us on a journey through YouTube binges, Wikipedia rabbit holes and bouts of staring out the window -- and encourages us to think harder about what we're really procrastinating on, before we run out of time. … what will the attendees learn?

FDA has had another active year on DSCSA implementation, including issuing guidance documents and holding several meetings. This session will provide an opportunity to hear directly from the agency on its guidance, the expected release of the “National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers,” current implementation efforts, and overall expectations for the pharmaceutical supply chain.

Interact with DEA and discuss current topics in controlled substances regulation.

Empty shelves? Huge price increases? What the truck is going on?!

Approximately 80 percent of America's freight spend is on truck transportation, and trucking is the most vital mode serving healthcare distribution. Boyle Transportation’s Andrew Boyle will provide insight into the economic and regulatory dynamics affecting the healthcare supply chain.

This session will include an overview by GS1 of the EPCIS standard and implementation guideline, a critical component to successfully exchange data under the DSCSA. A service provider panel will then talk through EPCIS implementation progress and lessons learned to date from their customer experiences.

Learn about the policies legislators and regulators are addressing on issues related to: pandemic preparedness, opioid abuse and prescription drug pricing, as well as an outlook on the 2022 elections.

This session will provide an update on current guidance and initiatives related to the 340B Drug Pricing Program as well as top-of-mind operational issues for distributors and manufacturers.

Today we are handling greater workloads and balancing the demands of career and family. The ability to stay positive, manage our emotions and work under pressure are key to success in the workplace. Hear stories and recommendations to develop a growth mindset, gain optimism and reduce stress while maintaining a positive mindset. Attendees will walk away with information and strategies you can apply immediately, including understanding your core values, learning happy habits, and overcoming a negativity bias, so we can be more productive and less stressed at work and home.

Distributor teams will outline their specific plans about DSCSA activities. Presenters will discuss their approach to several topics and answer questions from the audience. Topics highlighted will include:

• Aggregation and inference;
• Data standards and the use of identifiers;
• Verification;
• Master data complexities;
• Grandfathering; and,
• Communications and expectations for trading partners.

Hear about recent work to update HDA’s Contract and Chargeback Administration Guidelines for Electronic Data Interchange (EDI), including the 845 Price Authorization Acknowledgment/Status and the 849 EDI Document: Response to Product Transfer Account Adjustment transaction sets. Learn where contracts and chargebacks processing might head in a post-DSCSA-implementation future.

Active shooter incidents are often unpredictable and evolve quickly. In the midst of the chaos, you can play an integral role in mitigating the impacts of these incidents. This session will provide information and resources you can use to enhance preparedness and response to an active shooter incident as a leader, manager and employee.

Panelists from the pharmacy community will share their current thinking, approaches and challenges regarding the implementation of DSCSA. Topics to be addressed will include the structure of, and planning toward, a 2023 system; cost concerns; scanning and hardware upgrades across the dispensing community; suspect and illegitimate product reporting; and dispensers expectations of FDA and upstream suppliers.

This session will explore recent changes in state and federal reimbursement policy and what impact they have on the pharmaceutical supply chain.

In 2021, HDA launched Health Delivered, a multiyear, multimedia campaign highlighting the critical role and value of the association’s distributor member companies with policymakers and key audiences. HDA-member professionals have unique perspective and experiences in moving millions of medicines, products and supplies across the healthcare supply chain. In this session, you will learn more about HDA’s industry storytelling efforts — and how you can participate in and amplify Health Delivered through your own organization.

When DSCSA is fully implemented in 2023, manufacturers will not only be selling quality products downstream, but they will be sending quality data with each transaction. Accurate data are foundational to many pieces of DSCSA. As manufacturers send or prepare to send data it has become clear that there are common best practices that manufacturers engage in to avoid exceptions downstream. This session will cover best practices; how to engage your quality, compliance and distribution center teams; and develop a cross-functional approach to data quality.

Attendees will have the opportunity to discuss current operational issues associated with traceability implementation. Choose a topic of interest, rotate through tables, and convene with peers in small roundtable discussions, hosted by industry experts. Highlights from the discussions will be shared at the end of the session. Topics Include:

• EPCIS
• What to ask your vendor/how to choose your vendor
• Master data complexities;
• GS1 and tracing
• help desk/common questions

Specializing in analyzing information from IQVIA’s premier sales, prescription, promotional and medical databases, Doug Long will take a first look at the latest industry data and emerging market trends for branded and generic pharmaceutical and specialty product sales. Long will offer his perspective on a range of vital pharmaceutical topics, including global market trends, industry forecasts, research and development, marketing practices, blockbuster drugs, patent expirations and generic trends, biotechnology and more. He also will analyze how emerging trends will affect strategic business plans in the coming year and beyond.

We are more connected — yet disconnected — than ever before. And the “Loneliness Epidemic” is beginning to take over many developed countries. How do we stop that? Learn about the “Seven Deadly Habits That Send Your Conversation to the Emergency Room” and the five skills you need to develop to be more interesting than a cell phone. Standing out from the crowd and making real connections are important for both your personal and professional lives. This session will show you how to do it in less than an hour. Attendees will walk away with easy solutions to implement — and a few laughs, too!